Tharimmune Inc (THAR) - Prakiraan volume dodolan

Simbol resmi perusahaan Tharimmune Corp (THAR)

Tharimmune, Inc. (THAR) is developing a unique immunotherapy to combat oncological symptoms, which is supported by the company's future sales projections. The value of 0.00 reflects the latest metric level. A high barrier to entry is ensured by complex antibody synthesis and patents. The startup is currently focusing on launching phase II clinical trials of its targeted drugs.

THAR - Prakiraan volume dodolan Tharimmune, Inc. ing rentang 21.02.2024 - 18.02.2026

Rincian analitis lan laporan data perusahaan Tharimmune Corporation (THAR)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:THAR Tharimmune Inc
Produk merek Tharimmune Corp

Selecting stocks with a high margin of safety begins with an analysis of projected revenue. This metric assesses the expected cash inflow from product sales, where stable growth confirms the maturity of business processes. For Tharimmune, Inc. (THAR), this indicator depends directly on the success of partnerships in immuno-oncology and vaccine development. The trend in sales expectations for the company's products reflects the commercial potential of its scientific research. By analyzing this chart, an investor determines the balance between business stagnation and scaling.

Pesaing Tharimmune, Inc.

Prakiraan volume dodolan ONC|HALO (Halozyme) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan RVMD (revmed.com)|Dodolan mangsa ngarep perusahaan Ascentage (AAPG)|CGON: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan UroGen Pharma Ltd.|BCAX: Prakiraan volume dodolan|PSNL - Dodolan mangsa ngarep perusahaan|ERAS (Erasca Oncology) - Prakiraan volume dodolan|Prakiraan volume dodolan Delcath Systems, Inc.|Prakiraan pendapatan perusahaan ymabs.com (YMAB)|Prakiraan pendapatan perusahaan AURA (Aura Biosciences, Inc.)|Candel Therapeutics - Volume dodolan mangsa ngarep perusahaan|Accuray Inc. (ARAY) - Volume dodolan sing dikarepake perusahaan|SELLAS Life Sciences Group, Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan ACTU (Actuate Therapeutics, Inc.)|Citius Oncology (CTOR) - Prakiraan pendapatan perusahaan|HURA - Dodolan mangsa ngarep perusahaan|TARA (Protara Therapeutics, Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan Fate Therapeutics Inc|Prakiraan volume dodolan WHWK|Prakiraan volume dodolan TScan Therapeutics Inc (TCRX)|Prakiraan pendapatan perusahaan championsoncology.com CSBR|XBIT - Volume dodolan mangsa ngarep perusahaan|CVM - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan OSTX (OS Therapies)|RADX: Prakiraan volume dodolan|Artiva Biotherapeutics Inc. - Pendapatan mangsa ngarep perusahaan|ANL (Adlai Nortye) - Prakiraan volume dodolan|Prakiraan volume dodolan verupharma.com|Volume dodolan mangsa ngarep perusahaan TPST (tempesttx.com)|Volume dodolan mangsa ngarep perusahaan Xilio Therapeutics Inc XLO|Prakiraan volume dodolan RENB (Enochian BioSciences)|Mural Bio - Prakiraan pendapatan perusahaan|KAPA - Prakiraan pendapatan perusahaan|OnKure Therapeutics (OKUR) - Volume dodolan mangsa ngarep perusahaan|GDTC: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Curis Corp (CRIS)|APLM (apollomicsinc.com) - Prakiraan volume dodolan|Prakiraan volume dodolan Advanced Biomed Inc|Prakiraan volume dodolan GNPX|Volume dodolan mangsa ngarep perusahaan Calidi Biotherapeutics Inc. CLDI|Prakiraan pendapatan perusahaan Sunshine Biopharma Inc. SBFM|Dodolan mangsa ngarep perusahaan Xenetic Biosciences (XBIO)|SLRX - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Kitov Pharma|AON (AONC) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan BeiGene|Prakiraan pendapatan perusahaan checkpointtx.com|Prakiraan pendapatan perusahaan ELEV (Elevation Oncology)|Prakiraan volume dodolan ICAD|Ikena Oncology - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Notable Labs, Ltd. NTBL|VIRX: Prakiraan pendapatan perusahaan|MOR - Prakiraan pendapatan perusahaan|NAYA Bio (NAYA) - Volume dodolan mangsa ngarep perusahaan|AAPGV: Prakiraan volume dodolan